Post-transfusion Hepatitis C Virus Infection and the Hidden Burden of Warm Blood Transfusion in a Resource-Limited Setting: An Analytical Cross-Sectional Study from Mbujimayi, Democratic Republic of Congo
Résumé
Background Blood transfusion remains a cornerstone of clinical care but continues to pose risks when biosafety standards are not rigorously applied. In the Democratic Republic of the Congo (DRC), more than 90% of transfusions are delivered as warm transfusions, in which blood is released before full infectious marker screening is completed. This study aimed to quantify the additional risk of hepatitis C virus (HCV) transmission associated with this practice in Mbujimayi. Methods We conducted a prospective analytical cross-sectional study in four high transfusion-volume hospitals of Mbujimayi. A total of 223 previously transfused individuals (≥ 2 months post-transfusion) were enrolled and stratified into exposed (warm transfusion) and unexposed (cold transfusion) groups. Anti-HCV antibodies were detected using an HCV Scan rapid immunochromatographic assay performed on serum. Crude (cOR) and adjusted (aOR) odds ratios with 95% confidence intervals were estimated using bivariate analyses and multivariable logistic regression in IBM SPSS Statistics version 27, p < 0.05 was considered statistically significant. Results The post-transfusion HCV seroprevalence was 4.9% (11/223). After adjustment, two factors remained independently associated with HCV seropositivity: receiving more than one transfusion (aOR = 5.41; 95% CI: 1.22–24.02; p = 0.027) and unemployment (aOR = 4.66; 95% CI: 1.18–18.41; p = 0.028). Among those exposed to warm transfusion, repeated transfusions increased the likelihood of HCV infection tenfold (aOR = 10.03; 95% CI: 3.85–26.16; p < 0.001). Conclusion Warm transfusion, the prevailing modality in the DRC, constitutes a significant additional route of HCV transmission. Strengthening voluntary non-remunerated blood donation, ensuring uninterrupted screening for transfusion-transmitted infections, and enforcing systematic use of pre-tested blood units are critical strategies to reduce this preventable burden.
Citer ce document
Accès au document
Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter
Voir l'article sur le site de la revueAuteur(s)
Statistiques
Consultations : 1
Téléchargements : 0